Skip to main content
SpringerLink
Log in

Development of resistance to imipenem among nosocomial isolates ofPseudomonas aeruginosa

  • Letters
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Murray PR, Drew LW, Kobayashi GS, Thompson JH: Medical microbiology. CV Mosby, St. Louis, MO, 1990, p. 119–126.

    Google Scholar 

  2. Buckley MM, Brogden RN, Barradell LB, Goa KL: Imipenem/cilastatin. A reappraisal of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy. Drugs 1992, 44: 408–444.

    PubMed  Google Scholar 

  3. National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard. M7-A2. NCCLS, Villanova, PA, 1990.

    Google Scholar 

  4. Garner JS, Jarwis WR, Emori TG, Horan TC, Hughes JM: CDC definitions for nosocomial infections. Journal of Infection Control 1988, 16: 128–140.

    PubMed  Google Scholar 

  5. Koneman EW, Allen SD, Janda WM, Schreckenberger PC, Winn WC: Diagnostic microbiology. 4th ed. J.B. Lippincott, Philadelphia, 1992, p. 186–211.

    Google Scholar 

  6. National Committee for Clinical Laboratory Standards: Performance standards for antimicrobial susceptibility testing. Approved standard. M100-S3. NCCLS, Villanova, PA, 1991.

    Google Scholar 

  7. Maarten RV, Rozenberg M, Beumer H, Hoepelman IM, Verhoef J: Comparative in vitro antibacterial activity of sparfloxacin (AT-4140; rp 64206), a new quinolone. Antimicrobial Agents and Chemotherapy 1991, 35: 858–868.

    PubMed  Google Scholar 

  8. Gaynes RP, Culver DH: Resistance to imipenem among selected gram-negative bacilli, especiallyPseudomonas aeruginosa andEnterobacter species. Infection Control and Hospital Epidemiology 1992, 13: 10–14.

    PubMed  Google Scholar 

  9. Voutsinas D, Mauroudis T, Aulamis A, Giamarellou H: In vitro activity of meropenem, a new carbapenem, against multi-resistant antimicrobial. Journal of Antimicrobial Chemotherapy 1989, 24, Supplement A: 143–147.

    PubMed  Google Scholar 

  10. Hellinger WC, Brewer NS: Imipenem. Mayo Clinic Proceedings, 1991, 66:1074–1081.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Microbiology and Clinical Microbiology, Gülhane Military Medical Academy, 06018, Etlik, Ankara, Turkey

    A. C. Başustaoglu, H. Gün, M. A. Saraçlı, M. Baysallar & T. Haznedaroglu

Authors
  1. A. C. Başustaoglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Gün
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. A. Saraçlı
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Baysallar
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. T. Haznedaroglu
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Başustaoglu, A.C., Gün, H., Saraçlı, M.A. et al. Development of resistance to imipenem among nosocomial isolates ofPseudomonas aeruginosa . Eur. J. Clin. Microbiol. Infect. Dis. 14, 469–470 (1995). https://doi.org/10.1007/BF02114909

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02114909

Keywords

Search

Navigation